LIFE bioCEEd is a leading investor, actively supporting early-stage basic research and serving as a catalyst for translating visionary concepts into tangible healthcare solutions.
Our Position
WE UNDERSTAND PATIENTS
With a focus on diverse medical issues, LIFE bioCEEd is positioned as a patient-centric investment company, contributing to the well-being of patients in need of novel and effective treatment solutions.
WE UNDERSTAND TALENTS
Positioned as a bridge between promising scientific ideas and real-world solutions, LIFE bioCEEd facilitates the seamless transition of innovative technologies from research laboratories to thriving ventures.
€6 billion / year
Allocated by national & EU initiatives into basic academic research
24.000 patents (medtech & biotech)
Filed with European Patent Office (EPO) in 2022
Only 5% of patents reach market
Due to existing funding gap & lack of investor expertise in the sector
Academic research with translation potential
High volume of basic research non-utilized for prospective commercial applications